Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HCFA's PET Coverage Criteria Sets "Questionable Precedent" - NEMA

This article was originally published in The Gray Sheet

Executive Summary

The Health Care Financing Administration should not use a single design characteristic in deciding whether a positron emission tomography system is eligible for expanded coverage under Medicare, the National Electrical Manufacturers Association maintains.

You may also be interested in...



HCFA Meta-Analysis For PET Technology Review Published In JAMA

A meta-analysis of FDG-PET studies published the Feb. 21 Journal of the American Medical Association finds no evidence to conclude that modified gamma cameras are less accurate than dedicated PET scanners in diagnosing lung cancer.

HCFA Meta-Analysis For PET Technology Review Published In JAMA

A meta-analysis of FDG-PET studies published the Feb. 21 Journal of the American Medical Association finds no evidence to conclude that modified gamma cameras are less accurate than dedicated PET scanners in diagnosing lung cancer.

HCFA Expanded PET Imaging Coverage Limited To High-Performance Scanners

The Health Care Financing Administration's expanded Medicare coverage decision Dec. 15 for positron emission tomography (PET) scans will be limited to selected high-performance PET scanners.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT014379

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel